top of page

ACG
​
h.o.l.M.E.S.

Automated Clinical Guidelines

ACG-Blue-Pathology & Laboratory

Assays of Genetic Expression in Tumor Tissue as a Technique to Determine Prognosis in Patients with Breast Cancer
Adjunctive Techniques for Screening & Surveillance of Barrett’s Esophagus & Esophageal Dysplasia
Fecal Analysis in the Diagnosis of Intestinal Dysbiosis
Analysis of Human DNA as a Technique for Colorectal Cancer Screening
Drug Testing in Pain Management & Substance Use Disorder Treatment
Gene Expression Profile Testing & Circulating Tumor DNA Testing for Predicting Recurrence in Colon Cancer
Genetic Testing

Indicates Non-covered Service

In Vitro Chemoresistance & Chemosensitivity Assays
Genetic Testing for BRCA1 or BRCA2 for Hereditary Breast/Ovarian Cancer Syndrome & Other High-Risk Cancers
Laboratory Tests Post Transplant & for Heart Failure
Genetic Testing for Lynch Syndrome & Other Inherited Colon Cancer Syndromes
Intracellular Micronutrient Analysis
Measurement of Apolipoprotein B (apo B) & Apolipoprotein E (apo E) in Risk Assessment & Management of Cardiovascular Disease
Molecular Testing for the Management of Pancreatic Cysts, Barrett Esophagus, & Solid Pancreatic Lesions
Tumor/Genetic Markers
Noninvasive Prenatal Screening for Fetal Aneuploidies, Twin Zygosity, & Microdeletions Using Cell-Free Fetal DNA
Somatic Biomarker Testing (KRAS, NRAS, BRAF, HER2), Including Liquid Biopsy & MicroRNA Expression Testing, in Metastatic Colorectal Cancer
bottom of page